Skip to main content
Premium Trial:

Request an Annual Quote

Incyte Licenses Gene Patents and Databases to Agilent and Corning for Microarrays

NEW YORK, Jan 8 – In two separate agreements, Incyte has licensed its portfolio of gene patents and sequence information to both Agilent and Corning for use in their microarrays, Incyte announced Monday.

In the Corning agreement, the fiber-optics giant will have access to Incyte’s LifeSeq Gold human gene sequence database as well as Incyte’s ZooSeq animal database so it can manufacture human and animal genome microarrays. Corning’s microarray users will be able to click through on Incyte's website to Incyte’s database to buy additional genetic information as needed. Incyte will receive royalties on the sale of microarrays that Corning develops using this technology and databases.

Further financial terms of the deal were not disclosed.

“We believe this agreement will significantly enhance our ability to design and produce microarrays, and continues to strengthen our genetic content access supporting our planned full commercial microarray production in 2001,” Thomas Hinman, vice president of Corning Microarray technologies, said in a statement.

The Agilent agreement is substantially similar. Agilent has licensed Incyte’s cDNA clone sets in making animal and human gene expression microarrays. Researchers will have click-through access to Incyte’s LifeSeq gene-by-gene site so they can purchase additional information on specific genes. Incyte will also receive royalties from the sale of these arrays.

While Agilent already has custom oligonucleotide microarrays and other gene expression analysis tools on the market, Corning is a relative latecomer to the microarray market, having begun an effort in September to use its high-volume manufacturing processes to develop microarrays. In October, Corning completed a $10 million four-year agreement with MIT’s Whitehead Institute to develop the microarrays.

Incyte has entered into similar licensing agreements with two other microarray makers. It licensed its database of gene patents to Motorola, and its cDNA clones to PerkinElmer for commercialization of microarrays. In both agreements, Incyte is to receive royalties on the sale of microarrays.



The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.